Cenicriviroc mesylate/Tropifexor | Interleukin Related interleukin-related.com

Product Name :
Cenicriviroc mesylate/Tropifexor

Search keywords :
Tropifexor

drugId :
null

Target Vo:
Bile acid receptor FXR

Target Vo Short Name :
FXR

Moa_Name:
C-C chemokine receptor type 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Allergan Plc

Active Indication_Name:
Metabolic Dysfunction-Associated Steatotic Liver Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Loncastuximab web
MCM2 (YP7036) Mouse mAb Epigenetics
CD73 Antibody (YA528): CD73 Antibody (YA528) is a non-conjugated and Rabbit origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts